On June 30, JD Health declined 3.42% in regular trading, trading at HKD 32.76/share, with turnover of approximately HKD 85.94 million.

The decline was driven by two converging factors: sustained weakness across the Internet & Direct Marketing Retail sector and a sharp reduction in the company's share buyback pace. The HK tech sector had already accumulated over 7.5% in losses the prior week, with peers Ali Health falling 3.14% and JD Group declining 0.35% on the same day.

Critically, JD Health's June 29 buyback totaled only 101,700 shares for approximately HKD 3.33 million, a dramatic pullback from the June 22-26 period when the company consistently repurchased 500,000 shares daily at costs ranging from HKD 16.02 million to HKD 16.94 million per day. This abrupt reduction in buyback intensity—from roughly HKD 16-17 million daily to just HKD 3.3 million—raised market concerns that management's price-support commitment may be weakening, undermining a key pillar of investor confidence that had previously helped drive a 5% intraday rally on June 29.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)